Discovery of dual-target natural antimalarial agents against DHODH and PMT of Plasmodium falciparum: pharmacophore modelling, molecular docking, quantum mechanics, and molecular dynamics simulations

References

• M. Schmidt, V. Hrabcova, D. Jun, K. Kuca, and K. Musilek, Vector control and insecticidal resistance in the African malaria mosquito Anopheles gambiae, Chem. Res. Toxicol. 31 (2018), pp. 534–547. doi:10.1021/acs.chemrestox.7b00285.
   PubMed Web of Science ®Google Scholar
• M. Imwong, S. Nakeesathit, N.P.J. Day, and N.J. White, A review of mixed malaria species infections in anopheline mosquitoes, Malar. J. 10 (2011), pp. 253–266. doi:10.1186/1475-2875-10-253.
   PubMed Web of Science ®Google Scholar
• A.L. Conroy, D. Datta, and C.C. John, What causes severe malaria and its complications in children? Lessons learned over the past, BMC Med. 17 (2019), pp. 10–13. doi:10.1186/s12916-019-1291-z.
   PubMed Web of Science ®Google Scholar
• A. Singh, M. Maqbool, M. Mobashir, and N. Hoda, Dihydroorotate dehydrogenase: A drug target for the development of antimalarials, Eur. J. Med. Chem. 125 (2017), pp. 640–651. doi:10.1016/j.ejmech.2016.09.085.
   PubMed Web of Science ®Google Scholar
• L. Felipe, S.P. Azeredo, J.P. Coutinho, V.A.P. Jabor, P.R. Feliciano, M. Cristina, C.R. Kaiser, C. Maria, S. Menezes, A.S.O. Hammes, E. Raul, L.V.B. Hoelz, and N.B. De Souza, Plasmodium falciparum, antimalarial, and Pf- dihydroorotate dehydrogenase inhibitors, Eur. J. Med. Chem. 126 (2017), pp. 72–83. doi:10.1016/j.ejmech.2016.09.073.
   PubMed Web of Science ®Google Scholar
• L.V. Hoelz, F.A. Calil, M.C. Nonato, L.C. Pinheiro, and N. Boechat, Plasmodium falciparum dihydroorotate dehydrogenase: A drug target against malaria, Future Med. Chem. 10 (2018), pp. 1853–1874. doi:10.4155/fmc-2017-0250.
   PubMed Web of Science ®Google Scholar
• E.L. Flannery, L. Foquet, V. Chuenchob, M. Fishbaugher, Z. Billman, M.J. Navarro, W. Betz, T.M. Olsen, J. Lee, N. Camargo, B. Campo, S.A. Charman, S.C. Murphy, M.A. Phillips, S.H. Kappe, and S.A. Mikolajczak, Assessing drug efficacy against Plasmodium falciparum liver stages in vivo, JCI Insight 3 (2018), pp. 1–25. doi:10.1172/jci.insight.92587.
   Web of Science ®Google Scholar
• M.A. Phillips, J.W. Njoroge, M. Delves, R. Sinden, A. Ruecker, K.S. Wickham, R. Rochford, T. Rueckle, and X. Ding, A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria, Sci. Transl. Med. 7 (2015), pp. 1–30. doi:10.1126/scitranslmed.aaa6645.
   Web of Science ®Google Scholar
• M. Calas, M.L. Ancelin, G. Cordina, P. Portefaix, G. Piquet, V. Vidal-Sailhan, and H. Vial, Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: Comparison between mono- and bisquaternary ammonium salts, J. Med. Chem. 43 (2000), pp. 505–516. doi:10.1021/jm9911027.
   PubMed Web of Science ®Google Scholar
• S.G. Lee, Y. Kim, D. Tara, A. Nagata, and J.M. Jez, Structure and reaction mechanism of phosphoethanolamine methyltransferase from the malaria parasite Plasmodium falciparum, J. Biol. Chem. 287 (2012), pp. 1426–1434. doi:10.1074/jbc.M111.315267.
   PubMed Web of Science ®Google Scholar
• J.-Y. Choi, Y. Augagneur, C. Ben Mamoun, and D.R. Voelker, Identification of gene encoding Plasmodium knowlesi phosphatidylserine decarboxylase by genetic complementation in yeast and characterization of in vitro maturation of encoded enzyme, J. Biol. Chem. 287 (2011), pp. 222–232. doi:10.1074/jbc.M111.313676.
   PubMed Web of Science ®Google Scholar
• M. Álvarez-Bardón, Y. Pérez-Pertejo, C. Ordóñez, D. Sepúlveda-Crespo, N.M. Carballeira, B.L. Tekwani, S. Murugesan, M. Martinez-Valladares, C. García-Estrada, R.M. Reguera, and R. Balaña-Fouce, Screening marine natural products for new drug leads against trypanosomatids and malaria, Mar. Drugs 18 (2020), pp. 1–41. doi:10.3390/md18040187.
   Web of Science ®Google Scholar
• H. Yuan, Q. Ma, L. Ye, and G. Piao, The traditional medicine and modern medicine from natural products, Molecules 21 (2016), pp. 1–26. doi:10.3390/molecules21050559.
   Web of Science ®Google Scholar
• T.T. Ho, Q.T. Tran, and C.L. Chai, The polypharmacology of natural products, Future Med. Chem. 10 (2018), pp. 1361–1368. doi:10.4155/fmc-2017-0294.
   PubMed Web of Science ®Google Scholar
• K.S. Bhadoriya, N.K. Kumawat, S.V. Bhavthankar, M.H. Avchar, D.M. Dhumal, S.D. Patil, and S.V. Jain, Exploring 2D and 3D QSARs of benzimidazole derivatives as transient receptor potential melastatin 8 (TRPM8) antagonists using MLR and kNN-MFA methodology, J. Saudi Chem. Soc. 20 (2016), pp. S256–S270. doi:10.1016/j.jscs.2012.11.001.
   Web of Science ®Google Scholar
• G. Madhavi Sastry, M. Adzhigirey, T. Day, R. Annabhimoju, and W. Sherman, Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments, J. Comput. Aided. Mol. Des. 27 (2013), pp. 221–234. doi:10.1007/s10822-013-9644-8.
   PubMed Web of Science ®Google Scholar
• N.K. Salam, R. Nuti, and W. Sherman, Novel method for generating structure-based pharmacophores using energetic analysis, J. Chem. Inf. Model. 49 (2009), pp. 2356–2368. doi:10.1021/ci900212v.
   PubMed Web of Science ®Google Scholar
• P.D. Lyne, M.L. Lamb, and J.C. Saeh, Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring, J. Med. Chem. 49 (2006), pp. 4805–4808. doi:10.1021/jm060522a.
   PubMed Web of Science ®Google Scholar
• V. Suryanarayanan and S.K. Singh, Assessment of dual inhibition property of newly discovered inhibitors against PCAF and GCN5 through in silico screening, molecular dynamics simulation and DFT approach, J. Recept. Signal Transduct. 35 (2015), pp. 370–380. doi:10.3109/10799893.2014.956756.
   PubMed Web of Science ®Google Scholar
• J.H. Zothantluanga and D. Chetia, A beginner’s guide to molecular docking, Sci. Phytochem. 1 (2022), pp. 37–40.
   Google Scholar
• M. Sarma, M. Abdalla, J.H. Zothantluanga, F. Abdullah Thagfan, A.K. Umar, D. Chetia, T.N. Almanaa, and S.T. Al-Shouli, Multi-target molecular dynamic simulations reveal glutathione-S-transferase as the most favorable drug target of knipholone in Plasmodium falciparum, J. Biomol. Struct. Dyn. (2023), pp. 1–28.
   Web of Science ®Google Scholar
• J.H. Zothantluanga, M. Abdalla, M. Rudrapal, Q. Tian, D. Chetia, and J. Li, Computational investigations for identification of bioactive molecules from Baccaurea ramiflora and Bergenia ciliata as inhibitors of SARS-CoV-2 Mpro, Polycyclic Aromat. Compd. 43 (2022), pp. 2459–2487. doi:10.1080/10406638.2022.2046613.
   Web of Science ®Google Scholar
• M. Ahinko, S. Niinivehmas, E. Jokinen, and O.T. Pentikäinen, Suitability of MMGBSA for the selection of correct ligand binding modes from docking results, Chem. Biol. Drug Des. 93 (2019), pp. 522–538. doi:10.1111/cbdd.13446.
   PubMed Web of Science ®Google Scholar
• U. Norinder and C.A.S. Bergström, Prediction of ADMET properties, ChemMedChem 1 (2006), pp. 920–937. doi:10.1002/cmdc.200600155.
   PubMed Web of Science ®Google Scholar
• A. Llanos-cuentas, M. Casapia, R. Chuquiyauri, J. Hinojosa, N. Kerr, M. Rosario, S. Toovey, R.H. Arch, M.A. Phillips, F.D. Rozenberg, J. Bath, C.L. Ng, A.N. Cowell, E.A. Winzeler, D.A. Fidock, M. Baker, and J.J. Möhrle, Articles Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection : A proof-of-concept, open-label, phase 2a stud, Lancet Infect. Dis. 3099 (2018), pp. 1–10.
   Google Scholar
• A.M. Bobenchik, J.Y. Choi, A. Mishra, I.N. Rujan, B. Hao, D.R. Voelker, J.C. Hoch, and C. Mamoun, Identification of inhibitors of Plasmodium falciparum phosphoethanolamine methyltransferase using an enzyme-coupled transmethylation assay, BMC Biochem. 11 (2010), pp. 1–30. doi:10.1186/1471-2091-11-4.
   PubMed Web of Science ®Google Scholar
• S. Wang, Y. Li, J. Wang, L. Chen, L. Zhang, H. Yu, and T. Hou, ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage, Mol. Pharm. 9 (2012), pp. 996–1010. doi:10.1021/mp300023x.
   PubMed Web of Science ®Google Scholar
• M.L. Booker, C.M. Bastos, R. Wiegand, and E. Sybertza, Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model, J. Biol. Chem. 285 (2010), pp. 33054–33064. doi:10.1074/jbc.M110.162081.
   PubMed Web of Science ®Google Scholar
• P.T.P. Bedingfield, D. Cowen, P. Acklam, F. Cunningham, M.R. Parsons, G.A. McConkey, C.W.G. Fishwick, and A.P. Johnson, Factors influencing the specificity of inhibitor binding to the human and malaria parasite dihydroorotate dehydrogenases, J. Med. Chem. 55 (2012), pp. 5841–5850. doi:10.1021/jm300157n.
   PubMed Web of Science ®Google Scholar
• L.S. Ross, F.J. Gamo, M.J. Lafuente-Monasterio, O.M.P. Singh, P. Rowland, R.C. Wiegand, and D.F. Wirth, In vitro resistance selections for Plasmodium falciparum dihydroorotate dehydrogenase inhibitors give mutants with multiple point mutations in the drug-binding site and altered growth, J. Biol. Chem. 289 (2014), pp. 17980–17995. doi:10.1074/jbc.M114.558353.
   PubMed Web of Science ®Google Scholar
• X. Deng, R. Gujjar, F. El Mazouni, W. Kaminsky, N.A. Malmquist, E.J. Goldsmith, P.K. Rathod, and M.A. Phillips, Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds, J. Biol. Chem. 284 (2009), pp. 26999–27018. doi:10.1074/jbc.M109.028589.
   PubMed Web of Science ®Google Scholar
• R.E.K. Mandt, M.J. Lafuente-Monasterio, T. Sakata-Kato, M.R. Luth, D. Segura, A. Pablos-Tanarro, S. Viera, N. Magan, S. Ottilie, E.A. Winzeler, A.K. Lukens, F.J. Gamo, and D.F. Wirth, In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection model, Sci. Transl. Med. 11 (2019), pp. 1–14. doi:10.1126/scitranslmed.aav1636.
   Web of Science ®Google Scholar
• S.G. Lee, T.D. Alpert, and J.M. Jez, Crystal structure of phosphoethanolamine methyltransferase from Plasmodium falciparum in complex with amodiaquine, Bioorg. Med. Chem. Lett. 22 (2012), pp. 4990–4993. doi:10.1016/j.bmcl.2012.06.032.
   PubMed Web of Science ®Google Scholar
• A. Owoloye, Molecular docking analysis of Plasmodium falciparum dihydroorotate dehydrogenase pfDHODH from towards the design of effective inhibitors, Bioinformation 16 (2020), pp. 672–678. doi:10.6026/97320630016672.
   PubMed Web of Science ®Google Scholar
• A. Wadood and Z. Ulhaq, In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase, J. Mol. Graph. Model. 40 (2013), pp. 40–47. doi:10.1016/j.jmgm.2012.11.010.
   PubMed Web of Science ®Google Scholar
• R. Rawat and S.M. Verma, High-throughput virtual screening approach involving pharmacophore mapping, ADME filtering, molecular docking and MM-GBSA to identify new dual target inhibitors of PfDHODH and PfCytbc1 complex to combat drug resistant malaria, J. Biomol. Struct. Dyn. 39 (2021), pp. 5148–5159. doi:10.1080/07391102.2020.1784288.
   PubMed Web of Science ®Google Scholar
• J. Singh, S. Vijay, R. Mansuri, R. Rawal, K. Kadian, G.C. Sahoo, M. Kumar, and A. Sharma, Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target, PLoS One 14 (2019), pp. 1–21. doi:10.1371/journal.pone.0221032.
   Web of Science ®Google Scholar
• J. Singh, R. Mansuri, S. Vijay, G.C. Sahoo, A. Sharma, and M. Kumar, Docking predictions based Plasmodium falciparum phosphoethanolamine methyl transferase inhibitor identification and in ‑ vitro antimalarial activity analysis, BMC Chem. 13 (2019), pp. 1–13. doi:10.1186/s13065-019-0516-8.
   PubMed Web of Science ®Google Scholar
• K. Umar, J.H. Zothantluanga, J.A. Luckanagul, P. Limpikirati, and S. Sriwidodo, Structure-based computational screening of 470 natural quercetin derivatives for identification of SARS-CoV-2 Mpro inhibitor, PeerJ 11 (2023), pp. 14915–14935. doi:10.7717/peerj.14915.
   Web of Science ®Google Scholar
• M. Rudrapal, I. Celik, J. Khan, M.A. Ansari, M.N. Alomary, R. Yadav, T. Sharma, T.E. Tallei, P.K. Pasala, R.K. Sahoo, S.J. Khairnar, A.R. Bendale, J.H. Zothantluanga, D. Chetia, and S.G. Walode, Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations, J. King Saud Univ. - Sci. 34 (2022), pp. 101826–101852. doi:10.1016/j.jksus.2022.101826.
   PubMed Web of Science ®Google Scholar
• M. Rudrapal, I. Celik, S. Chinnam, M. Azam Ansari, J. Khan, S. Alghamdi, M. Almehmadi, J.H. Zothantluanga, and S.J. Khairnar, Phytocompounds as potential inhibitors of SARS-CoV-2 Mpro and PLpro through computational studies. Saudi J. Biol. 29 (2022), pp. 3456–3465.
   PubMed Web of Science ®Google Scholar